Barely Significant
← all excerpts

Control of nausea with palonosetron versus granisetron, both combined with dexamethasone, in patients receiving cisplatin- or anthracycline plus cyclophosphamide-based regimens.

Support Care Cancer · 2016 · PMC4967099 · PMID 27129842

1
hedged sentence
closest p
boldest claim

The sentences

also reported higher protection from acute nausea in patients treated with PALO than in those treated with ondansetron, although differences between the treatment arms did not reach statistical significance [ 20 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.